Cogent Biosciences annual revenue
2017
2018
2019
2020
Cogent Biosciences reported $7.9M in revenue for fiscal 2020, a decrease of 65.02% from the previous fiscal year.
View full Cogent Biosciences company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2020 | 2020-12-31 | $7.9M | −$14.6M | −65.02% |
| 2019 | 2019-12-31 | $22.5M | $12.8M | +131.14% |
| 2018 | 2018-12-31 | $9.7M | $1.4M | +16.44% |
| 2017 | 2017-12-31 | $8.4M | — | — |
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Cogent Biosciences filings at SEC.gov ↗